PRL and breast carcinoma: Clearly intrinsic differences in tumor cells themselves, including relative levels of PRLR isoforms and other signaling components play a role; different breast cancer cell lines, even of the same breast cancer subtype, exhibit different spectra of PRL activated signals in vitro [e.g., (137, 174)].